| Ytd | 365.02% | |
| 1y | 371.16% |
| Open | 54.63 | Prev Close | 54.20 | Low | 49.99 | High | 58.50 | Mkt Cap | 417.10M |
| Vol | 18.30K | Avg Vol | 78.55K | EPS | 0.12 | P/E | 416.58 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 15.97 | 200-d Avg | 12.14 | 1yr Est | 0.00 |
RFAI News
US stocks mixed, Nasdaq down 150 points. Dow up 0.10%, Nasdaq down 0.63%, S&P 500 down 0.30%. Co
Stock futures mixed, Nasdaq 100 down 100 points. Applied Optoelectronics falls after announcing $600
Increase driven by the fair-value recognition of 9BIT tokens received under the Company's cooperatio
Planet Green Holdings Corp (NYSE: PLAG) saw a sharp increase in pre-market trading after Curvature S
Dow gains 400 points, Materials sector up 2.3%, Werewolf Therapeutics up 113%, S&P PMI rises to
US stocks rise, Dow gains over 350 points as markets open Friday; Materials sector up 2%, utilitie
Shares of RF Acquisition Corp II (NASDAQ:RFAI) are surging Friday morning following Thursday SEC fil
RF Acquisition Corp II is surging Friday morning following Thursday SEC filings detailing the result
Ross Stores beats estimates with Q2 financial results, shares jump 9.1%. Other gainers include RFAI,
Werewolf Therapeutics shares surge 89.94% after hours as $33 million deal with EMD Serono brings fre
RF Acquisition Corp shares explode 473.45% after hours following Nanyang Biologics business combinat
RF Acquisition Corp II (NASDAQ: RFAI - Get Free Report)'s share price traded up 0.3% on Friday. The
Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", &#
The units will be listed on the Nasdaq Global Market ("Nasdaq") and trade under the ticker s